Therapeutic Activity of an Engineered Synthetic Killer Antiidiotypic Antibody Fragment against Experimental Mucosal and Systemic Candidiasis

類似資料

• Protection of Killer Antiidiotypic Antibodies against Early Invasive Aspergillosis in a Murine Model of Allogeneic T-Cell-Depleted Bone Marrow Transplantation
  著者:: Cenci, Elio, 等
  出版事項: (2002)
• Interplay between Protective and Inhibitory Antibodies Dictates the Outcome of Experimentally Disseminated Candidiasis in Recipients of a Candida albicans Vaccine
  著者:: Bromuro, Carla, 等
  出版事項: (2002)
• Immune Cell-Mediated Protection against Vaginal Candidiasis: Evidence for a Major Role of Vaginal CD4(+) T Cells and Possible Participation of Other Local Lymphocyte Effectors
  著者:: Santoni, Giorgio, 等
  出版事項: (2002)
• Transgenic Killer Commensal Bacteria as Mucosal Protectants
  著者:: Polonelli, Luciano
  出版事項: (2001)
• Transgenic Killer Commensal Bacteria as Mucosal Protectants
  著者:: Luciano Polonelli
  出版事項: (2001-01-01)